Results 161 to 170 of about 6,454 (219)

Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review. [PDF]

An Bras Dermatol
El-Amawy HS.
europepmc   +1 more source

Tirzepatide for Heart Failure and Obesity (Correspondence) [PDF]

Mandrola, John, Marine, Joseph, Prasad, Vinay   +2 more
core   +1 more source

Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management. [PDF]

Endocrinol Diabetes Metab
Abdul-Hafez HA, Awashra A, Bdir S, Saife S, Salah Q, Barbarawi M, Swaileh T, Emara A, Elgendy MS, Shubietah A.   +9 more
europepmc   +1 more source

Low discontinuation rate of tirzepatide treatment in Japanese patients with diabetes mellitus; importance of traditional Japanese diet. [PDF]

J Health Popul Nutr
Hiraide T, Suzuki Y, Yamamoto S, Yagihashi S, Sano M.   +4 more
europepmc   +1 more source

Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial. [PDF]

Diabetes Care
Snaith JR, Frampton R, Samocha-Bonet D, Greenfield JR.   +3 more
europepmc   +1 more source

Beyond Diabetes: The Vasculoprotective Effects and Anti-Atherosclerotic Potential of Tirzepatide. [PDF]

Int J Mol Sci
Rzepiński Ł, Tywoniuk A, Jaraczewska J, Al-Shaer A, Wiciński M.   +4 more
europepmc   +1 more source

Resolution of severe lumbar spinal epidural lipomatosis following tirzepatide-induced weight loss: illustrative case. [PDF]

J Neurosurg Case Lessons
Tazhibi M, Liu DD, Chalif JI, Ali R, Chi JH.   +4 more
europepmc   +1 more source

Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial.

JAMA Intern Med
Horn DB, Linetzky B, Davies MJ, Laffin LJ, Wang H, Murphy MA, Zimner-Rapuch S, Lau E, Arad AD, Lee CJ.   +9 more
europepmc   +1 more source

FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide/Tirzepatide in CVD Patients With Overweight/Obesity. [PDF]

JACC Adv
Do D, Murugiah K, Sawano M, Goodwin Cartwright BM, Rodriguez PJ, Gratzl S, Curtis LH, Jastreboff A, Lu Y, Stucky NL.   +9 more
europepmc   +1 more source

Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control. [PDF]

Rambam Maimonides Med J
Bonga KN, Padhan M.
europepmc   +1 more source